Search

Author/Creator Peer, Cody

1. A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1–3 inhibitor, cediranib, in recurrent women's cancers with biomarker analyses. Issue 1 (25th July 2019)

Authors:
Zimmer, Alexandra S.; Nichols, Erin; Cimino-Mathews, Ashley; Peer, Cody; Cao, Liang; Lee, Min-Jung; Kohn, Elise C.; Annunziata, Christina M.; Lipkowitz, Stanley; Trepel, Jane B.; Sharma, Rajni; Mikkilineni, Lekha; Gatti-Mays, Margaret; Figg, William D.; Houston, Nicole D.; Lee, Jung-Min
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A phase I study of TRC105 anti‐endoglin (CD105) antibody in metastatic castration‐resistant prostate cancer. (8th June 2015)

Authors:
Karzai, Fatima H.; Apolo, Andrea B.; Cao, Liang; Madan, Ravi A.; Adelberg, David E.; Parnes, Howard; McLeod, David G.; Harold, Nancy; Peer, Cody; Yu, Yunkai; Tomita, Yusuke; Lee, Min‐Jung; Lee, Sunmin; Trepel, Jane B.; Gulley, James L.; Figg, William D.; Dahut, William L.
Journal:
BJU international
Issue:
Volume 116:Number 4(2015:Oct.)
Page Start:
546
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. DDEL-04. Pharmacokinetic/Pharmacodynamic analysis of the DNA methyltransferase inhibitor 5-azacytidine shows adequate brain tissue penetration with intravenous administration in a DIPG mouse patient-derived xenograft model. (3rd June 2022)

Authors:
Groves, Andrew; Jones, Kristen; Cameron, Amy; Panditharatna, Eshini; Morrow, Murry; Mozarsky, Brett; McCully, Cynthia; Peer, Cody; De Nguyen, Quang-; Filbin, Mariella; Warren, Katherine
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 1
Page Start:
i34
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. EPCT-09. CNS LEVELS OF PANOBINOSTAT IN A NON-HUMAN PRIMATE MODEL: COMPARISON OF BLOOD AND CEREBROSPINAL FLUID PHARMACOKINETIC METHODS AND MALDI MSI. (1st June 2021)

Authors:
Warren, Katherine; McCully, Cynthia Lester; Garcia, Rafael Cruz; Stopka, Sylwia; Regan, Michael; Aye, Thet; Zimmerman, Sara; Peer, Cody; Kramer, Josh; Breed, Matthew; Figg, W Douglas; Agar, Nathalie
Journal:
Neuro-oncology
Issue:
Volume 23(2021)Supplement 1
Page Start:
i48
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. EPCT-16. LENALIDOMIDE ACTIVITY IN PILOCYTIC ASTROCYTOMA AND OPTIC PATHWAY GLIOMAS: REPORT ON CHILDREN'S ONCOLOGY GROUP ACNS1022. (1st June 2021)

Authors:
Warren, Katherine; Vezina, Gilbert; Springer, Linda; Buxton, Allen; Peer, Cody; Figg, W Douglas; Fouladi, Maryam; Gajjar, Amar; Krailo, Mark; Bowers, Daniel
Journal:
Neuro-oncology
Issue:
Volume 23(2021)Supplement 1
Page Start:
i50
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. EXTH-100. EVALUATION OF PANOBINOSTAT PLASMA AND CEREBROSPINAL FLUID (CSF) PHARMACOKINETIC PROFILE FOLLOWING ADMINISTRATION OF THE CAPSULE FORMULATION FARYDAK® IN A NON-HUMAN (NHP) PRIMATE PRECLINICAL MODEL. (14th November 2022)

Authors:
McCully, Cynthia Lester; Warren, Katherine; Zimmerman, Sara; Peer, Cody; Killoran, Kristin; Garcia, Rafael Cruz; Figg, William; Widemann, Brigitte
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii233
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. EXTH-102. PLASMA AND CEREBROSPINAL FLUID (CSF) PHARMACOKINETICS (PK) OF MIRDAMETINIB IN A NON-HUMAN PRIMATE (NHP) MODEL. (14th November 2022)

Authors:
McCully, Cynthia Lester; Shearer, Todd; Gross, Andrea; Langseth, Abraham; Peer, Cody; Killoran, Kristin; Garcia, Rafael Cruz; Figg, William; Widemann, Brigitte
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii233
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. EXTH-25. THE CSF PENETRATION OF THE PROCASPASE-ACTIVATING COMPOUND (PAC-1) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN A NONHUMAN PRIMATE CSF ACCESS MODEL. (9th November 2020)

Authors:
Lester McCully, Cynthia; Shankarappa, Priya; Garcia, Rafael Cruz; Peer, Cody; Zakharov, Alexander; Fischer, James; Lyubimov, Alexander; Hergenrother, Paul; Thomas, Marvin; Figg, William; Warren, Katherine
Journal:
Neuro-oncology
Issue:
Volume 22(2020)Supplement 2
Page Start:
ii92
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. EXTH-64. COMPARISON OF PANOBINOSTAT CSF PENETRATION WITH CNS PENETRATION FOLLOWING SYSTEMIC ADMINISTRATION IN A PRE-CLINICAL NON-HUMAN PRIMATE MODEL. (12th November 2021)

Authors:
McCully, Cynthia Lester; Warren, Katherine; Zimmerman, Sara; Peer, Cody; Rafael, Cruz Garcia; Kramer, Joshua; Breed, Matthew; Figg, William Douglas; Agar, Nathalie; Widemann, Brigitte
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 6(2021)
Page Start:
vi177
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗